Molecular analysis of the digestive microbiota in a gnotobiotic mouse model during antibiotic treatment: Influence of Saccharomyces boulardii.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Anaerobe

• Publication date

  2008-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.anaerobe.2008.04.003PMID 18511310
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Saccharomyces boulardii produces a soluble anti-inflammatory factor that inhibits NF-kappaB-mediated IL-8 gene expression.

  2006cited by this paper
• Effect of Amoxicillin-Clavulanic Acid on Human Fecal Flora in a Gnotobiotic Mouse Model Assessed with Fluorescence Hybridization Using Group-Specific 16S rRNA Probes in Combination with Flow Cytometry

  2004cited by this paper
• Antibiotic-Associated Diarrhea Accompanied by Large-Scale Alterations in the Composition of the Fecal Microbiota

  2004cited by this paper
• Improvement of human faecal flora‐associated mouse model for evaluation of the functional foods

  2004cited by this paper
• Incidence and Risk Factors of Oral Antibiotic‐Associated Diarrhea in an Outpatient Pediatric Population

  2003cited by this paper
• Dose-Dependent Preventive Effect of Saccharomyces boulardii on clindamycin-induced Alterations in Intestinal Aerobic Flora of the Hamster

  2003cited by this paper
• Antibiotic‐associated diarrhoea and Clostridium difficile> in the community

  2003cited by this paper
• Original Articles

  2003cited by this paper
• Fluorescent hybridisation combined with flow cytometry and hybridisation of total RNA to analyse the composition of microbial communities in human faeces using 16S rRNA probes.

  2003cited by this paper
• Experimental effects of Saccharomyces boulardii on diarrheal pathogens.

  2002cited by this paper
• Inhibition of in vitro cell adherence of Clostridium difficile by Saccharomyces boulardii.

  2002cited by this paper
• Protection from gastrointestinal diseases with the use of probiotics.

  2001cited by this paper
• Saccharomyces boulardii Stimulates Intestinal Immunoglobulin A Immune Response to Clostridium difficileToxin A in Mice

  2001cited by this paper
• Effect of antimicrobial agents on the ecological balance of human microflora.

  2001cited by this paper
• Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients: a prospective study.

  2001cited by this paper
• Analysis of the Fecal Microflora of Human Subjects Consuming a Probiotic Product Containing Lactobacillus rhamnosusDR20

  2000cited by this paper
• The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii.

  2000cited by this paper
• Mechanisms of Colonisation and Colonisation Resistance of the Digestive Tract

  2000cited by this paper
• A molecular view of the intestinal ecosystem.

  2000cited by this paper
• Quantification of Bacterial Groups within Human Fecal Flora by Oligonucleotide Probe Hybridization

  2000cited by this paper
• Behaviour of Saccharomyces boulardii in recurrent Clostridium difficile disease patients

  1999cited by this paper
• Direct Analysis of Genes Encoding 16S rRNA from Complex Communities Reveals Many Novel Molecular Species within the Human Gut

  1999cited by this paper
• Saccharomyces boulardii Protease Inhibits the Effects of Clostridium difficile Toxins A and B in Human Colonic Mucosa

  1999cited by this paper
• Variations of Bacterial Populations in Human Feces Measured by Fluorescent In Situ Hybridization with Group-Specific 16S rRNA-Targeted Oligonucleotide Probes

  1998cited by this paper
• Mechanisms and management of antibiotic-associated diarrhea.

  1998cited by this paper
• Epidemiology, Risk Factors and Treatments for Antibiotic-Associated Diarrhea

  1998cited by this paper
• Adequacy of the Human Faecal Microbiota Associated Mouse as a Model for Studying the Ecology of the Human Intestinal Tract

  1996cited by this paper
• Prevention of beta-lactam-associated diarrhea by Saccharomyces boulardii compared with placebo.

  1995cited by this paper
• A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease.

  1994cited by this paper
• Optimizing fluorescent in situ hybridization with rRNA-targeted oligonucleotide probes for flow cytometric identification of microorganisms.

  1993cited by this paper
• Saccharomyces boulardii inhibits Clostridium difficile toxin A binding and enterotoxicity in rat ileum.

  1993cited by this paper
• Development and Stability of Human Faecal Flora in the Intestine of Ex-germ-free Mice

  1991cited by this paper
• Probiotics in human medicine.

  1991cited by this paper
• Stimulation of secretory IgA and secretory component of immunoglobulins in small intestine of rats treated withSaccharomyces boulardii

  1990cited by this paper
• Combination of 16S rRNA-targeted oligonucleotide probes with flow cytometry for analyzing mixed microbial populations

  1990cited by this paper
• Fluorescent-oligonucleotide probing of whole cells for determinative, phylogenetic, and environmental studies in microbiology

  1990cited by this paper
• Disposition kinetics of Saccharomyces boulardii in man and rat.

  1989cited by this paper
• Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study.

  1989cited by this paper
• Treatment of recurrent Clostridium difficile colitis with vancomycin and Saccharomyces boulardii.

  1989cited by this paper
• Impaired colonic fermentation of carbohydrate after ampicillin.

  1988cited by this paper
• Suppression by Saccharomyces boulardii of toxigenic Clostridium difficile overgrowth after vancomycin treatment in hamsters

  1987cited by this paper
• Prevention of Clostridium difficile induced mortality in gnotobiotic mice by Saccharomyces boulardii.

  1986cited by this paper
• Effects of the human intestinal flora on germ-free mice.

  1981cited by this paper
• Implantation of bacteria from the digestive tract of man and various animals into gnotobiotic mice.

  1980cited by this paper
• Bile acids, diarrhea, and antibiotics: data, speculation, and a unifying hypothesis.

  1977cited by this paper

• Saccharomyces boulardii Alleviates Ovalbumin‐Induced Pyroptosis Through Cyba and IL‐17 Signaling Pathway

  2025cites this paper
• The role and challenges of intratumoral microbiota in colorectal cancer immunotherapy

  2025cites this paper
• Current Evidence of Probiotics in Pediatrics with Short Bowel Syndrome, Is It Safe and Beneficial? A Literature Review

  2025cites this paper
• Resolution on the results of the Expert Council on the topic “Antibiotics, microbiota and probiotics: Strategies for the prevention of antibiotic-associated syndrome and antibiotic resistance in pediatrics”

  2025cites this paper
• Antibiotic-associated dysbiosis: modern strategy for microbiota restoration. A review

  2024cites this paper
• Advances in Yeast Probiotic Production and Formulation for Preventative Health

  2024cites this paper
• Saccharomyces cerevisiae boulardii accelerates intestinal microbiota maturation and is correlated with increased secretory IgA production in neonatal dairy calves

  2023cites this paper
• Saccharomyces boulardii CNCM I-745 supplementation during and after antibiotic treatment positively influences the bacterial gut microbiota

  2023cites this paper
• An Overview of Short-Bowel Syndrome in Pediatric Patients: Focus on Clinical Management and Prevention of Complications

  2023cites this paper
• Effects of Saccharomyces cerevisiae var. boulardii on growth, incidence of diarrhea, serum immunoglobulins, and rectal microbiota of suckling dairy calves

  2022cites this paper
• Strain engineering and metabolic flux analysis of a probiotic yeast Saccharomyces boulardii for metabolizing l-fucose, a mammalian mucin component

  2022cites this paper
• Probiotic Yeast Saccharomyces: Back to Nature to Improve Human Health

  2022cites this paper
• Do Primocolonizing Bacteria Enable Bacteroides thetaiotaomicron Intestinal Colonization Independently of the Capacity To Consume Oxygen?

  2021cites this paper
• Role of Recent Therapeutic Applications and the Infection Strategies of Shiga Toxin-Producing Escherichia coli

  2021cites this paper
• Probiotic yeast BR14 ameliorates DSS-induced colitis by restoring the gut barrier and adjusting the intestinal microbiota.

  2021cites this paper
• In Situ Biomanufacturing of Small Molecules in the Mammalian Gut by Probiotic Saccharomyces boulardii.

  2021cites this paper
• Impact of Probiotics on microbiota in the gut of antibiotic treated Vertebrates

  2021cites this paper
• Probiotic Yeasts and Vibrio anguillarum Infection Modify the Microbiome of Zebrafish Larvae

  2021cites this paper
• Saccharomyces boulardii CNCM I-745: A Non-bacterial Microorganism Used as Probiotic Agent in Supporting Treatment of Selected Diseases

  2020cites this paper
• Establishing Probiotic Saccharomyces boulardii as a Model Organism for Synthesis and Delivery of Biomolecules

  2020cites this paper
• Human gut microbiota evaluation and comparation after the separate or combined antibiotics exposure using the simulator of human intestinal microbial ecosystem (SHIME)

  2020cites this paper
• Clinical efficacy of drugs based on probiotic strains of Saccharomyces boulardii

  2020cites this paper
• A probiotic yeast-based immunotherapy against Clostridioides difficile infection

  2020cites this paper
• The effect of probiotics on ıntestinal motility in an experimental short bowel model 1

  2020cites this paper
• Amoxicillin Increased Functional Pathway Genes and Beta-Lactam Resistance Genes by Pathogens Bloomed in Intestinal Microbiota Using a Simulator of the Human Intestinal Microbial Ecosystem

  2020cites this paper
• Diversity of Saccharomyces boulardii CNCM I-745 mechanisms of action against intestinal infections

  2019cites this paper
• Protective effect of Saccharomyces boulardii on intestinal mucosal barrier of dextran sodium sulfate-induced colitis in mice

  2019cites this paper
• Contrasting Strategies: Human Eukaryotic Versus Bacterial Microbiome Research

  2019cites this paper
• Abundance of Probiotics and Butyrate-Production Microbiome Manages Constipation Via Short-Chain Fatty Acids Production and Hormones Secretion.

  2019cites this paper
• Saccharomyces boulardii CNCM I-745 supplementation reduces gastrointestinal dysfunction in an animal model of IBS

  2017cites this paper
• Prospective randomized controlled study on the effects of Saccharomyces boulardii CNCM I-745 and amoxicillin-clavulanate or the combination on the gut microbiota of healthy volunteers

  2017cites this paper
• Rôle de l’hème dans la primo-colonisation de Bacteroides thetaiotaomicron dans le tractus digestif

  2017cites this paper
• Heritable components of the human fecal microbiome are associated with visceral fat

  2016cites this paper
• Antioxidative effects in vivo and colonization of Lactobacillus plantarum MA2 in the murine intestinal tract

  2016cites this paper
• Prospective randomized controlled study on the effects of Saccharomyces boulardii CNCM I-745 and amoxicillin-clavulanate or the combination on the gut microbiota of healthy volunteers

  2016cites this paper
• Gleaning Insights from Fecal Microbiota Transplantation and Probiotic Studies for the Rational Design of Combination Microbial Therapies

  2016cites this paper
• Discovering probiotic microorganisms: in vitro, in vivo, genetic and omics approaches

  2015cites this paper
• A sensitive bacterial-growth-based test reveals how intestinal Bacteroides meet their porphyrin requirement

  2015cites this paper
• The Efficacy of Saccharomyces boulardii CNCM I-745 in Addition to Standard Helicobacter pylori Eradication Treatment in Children

  2015cites this paper
• Saccharomyces boulardii CNCM I-745 supports regeneration of the intestinal microbiota after diarrheic dysbiosis – a review

  2015influential citation
• Flow cytometry as an auxiliary tool for the selection of probiotic bacteria.

  2015cites this paper
• Probiotics or antibiotics: future challenges in medicine.

  2015cites this paper
• The microbial community structure of the cotton rat nose.

  2015cites this paper
• Saccharomyces boulardii unterstützt die Regenerierung der intestinalen Mikrobiota bei diarrhoischen und antibiotischen Dysbiosen

  2015cites this paper
• Saccharomyces cerevisiae var. boulardii as a eukaryotic probiotic and its therapeutic functions

  2015influential citation
• Effect of probiotic administration on the intestinal microbiota, current knowledge and potential applications.

  2014cites this paper
• Use of probiotics to correct dysbiosis of normal microbiota following disease or disruptive events: a systematic review

  2014cites this paper
• Role of yeasts in healthy and impaired gut microbiota: the gut mycome.

  2014cites this paper
• Évaluation chez le porcelet de l'effet des probiotiques « Pediococcus acidilactici » et « Saccharomyces cerevisiae ssp. boulardii » sur le microbiote intestinal et sur les réponses innées et acquises lors d'une infection à « Salmonella Typhimurium DT 104 »

  2013cites this paper
• Altered Gut Microbiota Promotes Colitis-Associated Cancer in IL-1 Receptor–Associated Kinase M–Deficient Mice

  2013cites this paper
• Role of Probiotics in Short Bowel Syndrome in Infants and Children—A Systematic Review

  2013cites this paper
• Role of Gut Microbiome-Host Metabolic Interactions in Metabolic Diseases

  2012cites this paper
• Models for the study of Clostridium difficile infection

  2012cites this paper
• Comparative evaluation of establishing a human gut microbial community within rodent models

  2012cites this paper
• Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders

  2012cites this paper
• Saccharomyces boulardii: a summary of the evidence for gastroenterology clinical practice in adults and children.

  2011cites this paper
• Saccharomyces boulardii and Candida albicans experimental colonization of the murine gut.

  2011cites this paper
• Bacterial adaptation to the gut environment favors successful colonization

  2011cites this paper
• Biological control of human digestive microbiota using antimicrobial cultures and bacteriocins

  2011cites this paper
• Recent developments and perspectives in the investigation of probiotic effects.

  2010cites this paper
• Metody selekcji mikroorganizmów o właściwościach probiotycznych

  2010cites this paper
• [Saccharomyces boulardii modulates dendritic cell properties and intestinal microbiota disruption after antibiotic treatment].

  2010cites this paper
• Probiotic bacteria and intestinal epithelial barrier function.

  2010cites this paper
• [A new era in gut research concerning interactions between microbiota and human health].

  2010cites this paper
• Chapter 31 – Human Flora-associated Animals as a Model for Studying Probiotics and Prebiotics

  2010cites this paper
• Systematic review and meta-analysis of Saccharomyces boulardii in adult patients.

  2010cites this paper
• Saccharomyces boulardii module les propriétés des cellules dendritiques et le déséquilibre du microbiote intestinal après un traitement antibiotique

  2010cites this paper
• Summary of probiotics effects on epithelial barrier function in vitro and in vivo

  2010cites this paper
• Une ère nouvelle dans le domaine des interactions entre le microbiote et la santé humaine

  2010cites this paper
• Production of an antibacterial substance in the digestive tract involved in colonization-resistance against Clostridium perfringens.

  2010cites this paper
• Evidence-based review of probiotics for antibiotic-associated diarrhea and Clostridium difficile infections.

  2009cites this paper
• Targeting the human microbiome with antibiotics, probiotics, and prebiotics: gastroenterology enters the metagenomics era.

  2009cites this paper
• EVALUATION OF A PROBIOTIC (LEVUCELL SB ® ) AND A PREBIOTIC (AGRIMOS ® ) ON PERFORMANCE, HEALTH AND FECAL MICROFLORA OF VEAL CALVES

  2009cites this paper
• Evidence-based review of probiotics for antibiotic-associated diarrhea and Clostridium difficile infections q

  year unknowncites this paper
• Clinical and Experimental Gastroenterology Dovepress

  year unknowncites this paper